Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Anti Viral Agents. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel trityl-protection route for anti-HBV nucleoside analogs. High purity, scalable process for reliable pharmaceutical intermediate supplier.
Advanced patent CN102060876A details a safer, cost-effective route for high-purity tenofovir intermediates, eliminating hazardous reagents for scalable API manufacturing.
Advanced synthesis of entecavir intermediate via novel iron-catalyzed Friedel-Crafts alkylation. Offers superior purity, cost efficiency, and scalable supply chain solutions.
Novel low-cost preparation method for oseltamivir using benzylamine ring-opening and Boc protection strategies suitable for industrial scale-up.
Discover the patented supercritical ammonia synthesis route for 6,6-dimethyl-3-azabicyclo[3.1.0]hexane. Enhance purity and reduce solvent costs for antiviral intermediates.
Novel patent CN115109104B offers mild conditions and reduced purification steps for cordycepin, ensuring supply chain stability and cost efficiency for pharmaceutical intermediates.
Patent CN1115343C details a novel enzymatic route for chiral cyclopentene amines, offering cost-effective API intermediate manufacturing with high enantiomeric purity.
Patent CN107098936A reveals mild catalytic route for TAF intermediates ensuring high purity and supply chain stability for global pharmaceutical manufacturing partners.
Discover the patented six-step synthesis for 6-fluoro-3-hydroxy-2-pyrazinamide. This method offers high yields, mild conditions, and significant cost reduction in pharmaceutical intermediate manufacturing.
Patent CN115703796A reveals a high-yield route for Remdesivir intermediates using methylthio-substitution, offering significant cost reduction and supply chain stability for API manufacturing.
Novel serine-based route for methyl 2,3-diaminopropionate. Mild conditions, high yield, scalable process for peptidomimetic inhibitor manufacturing.
Novel serine-based route for methyl 2,3-diaminopropionate offers cost reduction and mild conditions for peptide inhibitor manufacturing.
Patent CN101475572A reveals a high-purity synthesis route for triacetylganciclovir using monoacetylguanine, offering significant cost reduction and scalability for API manufacturing.
Patent CN105503742A reveals visible light photocatalysis for high-yield difluoroalkyl uracil synthesis offering supply chain stability and cost efficiency for pharmaceutical manufacturing.
Patent CN110305163A reveals optimized TAF synthesis. Enhances purity and reduces impurities for reliable pharmaceutical intermediates supply chain stability.
Patent CN107674072B reveals a scalable resolution method for dihydropyrimidine intermediates using L-tartaric acid, offering superior optical purity and cost-effective manufacturing for pharmaceutical supply chains.
Advanced synthesis of triacetyl ganciclovir via monoacetyl guanine condensation. Superior purity, reduced isomers, and cost-effective manufacturing for global pharmaceutical supply chains.
Patent CN101391997B details a safer emtricitabine intermediate synthesis using triphosgene. Discover cost reduction in API manufacturing and enhanced supply chain reliability.
Novel 4-step synthesis of antiviral intermediate Phthiobuzone reduces bromine usage and improves scalability for reliable pharmaceutical supply chains.
Patent CN114478580A reveals a recyclable ionic liquid method for synthesizing pyrano thiazolo pyrimidine derivatives, offering high purity and reduced waste for API manufacturing.